Michael Toomey

Michael Toomey Analyst Performance

US Medtech Analyst, Senior Vice President at Jefferies Financial Group

Michael Toomey is a stock analyst at Jefferies Financial Group in the healthcare sector, covering 3 publicly traded companies. Over the past year, Michael Toomey has issued 3 stock ratings, including buy and hold recommendations. While full access to Michael Toomey's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Toomey's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 1 Years
Buy Recommendations
50.00% 2 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%2 ratings
Hold50.0%2 ratings
Sell0.0%0 ratings

Out of 4 total stock ratings issued by Michael Toomey at Jefferies Financial Group, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
2 companies
NYSE
33.3% of companies on NYSE
1 company

Michael Toomey, an analyst at Jefferies Financial Group, currently covers 3 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
3 companies
100.0%

Michael Toomey of Jefferies Financial Group specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
3 companies
100.0%

Michael Toomey's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
MiniMed Group Inc stock logo
MMED
MiniMed Group
10/12/2026Initiated Coverage$19.71$22.00Hold
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
10/12/2026Initiated Coverage$17.63$30.00Buy
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
10/12/2026Initiated Coverage$17.86$30.00Buy
Solventum Corporation stock logo
SOLV
Solventum
9/11/2025Initiated Coverage$71.25$80.00Hold